The Next Phase: Exploring Innovation in Clinical Trials

When you’re halfway around the world and you need to make a purchase, it’s as easy as pulling a plastic card out of your wallet and swiping. Why can’t we have the same simplicity with our healthcare data?  The answer is complex, according to Arlen Meyers, President and CEO of the Society of Physician Entrepreneurs. A medical doctor and a startup consultant, Dr. Meyers, discusses all the ways we can work toward ethical data exchange and improve on what he calls our “sick care system.”  Join us as we discuss:What interoperability for healthcare and clinical trial data meansBarriers to interoperabilityWhy physicians and business people must work together on data exchangeHow owning their data can empower patients in clinical trialsWhy technology is essential for data exchange between physicians, patients, and healthcare organizations

You wouldn’t take a drug if you didn’t know if it was going to help you. It might surprise you to hear millions of people do this every day. Not because they don’t care or don’t want to know, but because they live in a system that wasn’t built for them.  This is the reality for underrepresented communities and racial and ethnic minorities who have been all-but-locked-out of the clinical trial process.  Tiffany Whitlow, Co-Founder & Chief Development Officer at Acclinate, shares her insights about the depth of inequity in the clinical trials system and how we can fix it.  Join us as we discuss:How Tiffany co-founded a company made to bring DEI back into clinical trialsThe surprising statistics surrounding inequity in healthcareHow Acclinate is changing the system to bring clinical trials to those who need them mostWhat pharmaceutical sponsors and research sites need to do to increase clinical trial equity

Ryan Jones, co-founder and CEO of Florence Healthcare, dives into the revolutionary changes in clinical research following the pandemic. He discusses the increased empowerment of research sites and patients through technology and emphasizes the importance of expanding diversity in trials by reaching underserved communities. Jones highlights the significance of patient engagement and autonomy in shaping future drug development. With a focus on dual expertise, he addresses the skills necessary to navigate the intersection of technology and clinical research.

This episode dives into epidemiology and real-world evidence, as host Blake Adams and Paul Petraro, Global Head of Real World Evidence, Data Analytics, Value Evidence and Outcomes for Boehringer Ingelheim explore the evolution of real-world data, its use cases, and the need for trust and transparency when leveraging information across the clinical research industry.

Tracey Robertson, Global Process Lead at Boehringer Ingelheim, discusses the transformational impact of real-world data in clinical trials. She highlights how digital technologies can enhance patient and site experiences while ensuring effective and scalable trial methodologies. The conversation delves into the importance of patient centricity, navigating regulatory landscapes, and the need for strategic planning in tech adoption. Tracey emphasizes empowering participants with their health data to foster greater engagement and understanding in clinical research.

In this episode, Blake speaks with Michelle Shogren, Senior Director of Innovation at Bayer, about how incorporating the patient experience in decentralized models breathes innovation into clinical trials.

In this episode, host Blake Adams discusses investment trends in the clinical research industry with Joe Munda, Senior Vice President of First Analysis.

Join host Blake Adams for a conversation with Amir Lahav, Head of Digital R&D, Mitsubishi Tanabe Pharma Holdings America, about the innovative ways companies can approach decentralized trials in a post-pandemic world.

In this episode, brought to you by the Florence Diversity and Inclusion Committee, host Blake Adams and Leslie Byatt, clinical research manager for NMCCA and UNMCCC, discuss the importance of diversity – for both people and technology – across research initiatives.

In this episode, host Blake Adams and Sholeh Ehdaivand, founder, president and CEO of LMK Clinical Research Consulting, discuss Trial Master Files (TMF) and their pivotal role in the future of real-time collaboration between clinical research sites and sponsors.